Abstract-Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a potent endogenous secretagogue for chromaffin cells. We previously reported that PACAP coupled to the PAC1 receptor to evoke dihydropyridine-sensitive early (15 to 20 minutes) catecholamine secretion and cAMP response element binding protein-mediated trans-activation of the secretory protein chromogranin A promoter in PC12 pheochromocytoma cells. In this report, we studied whether the secretory and transcriptional responses elicited by PACAP were subject to desensitization. We found that PACAP evoked distinct immediate (initial, 0 to 20 minutes) and long-lasting (20 to 180 minutes) effects on catecholamine secretion. Initial secretory and chromogranin A trans-activation responses induced by PACAP were desensitized in a dose-dependent fashion after preexposure of cells to PACAP, and the IC 50 doses of PACAP for desensitization were Ϸ18-to Ϸ32-fold lower than the EC 50 activating doses for secretion or transcription. Desensitization of the initial secretion response was associated with decreased Ca 2ϩ influx through L-type voltage-operated Ca 2ϩ channels. Acute exposure to PACAP also triggered long-lasting (up to 3 hours), extracellular Ca 2ϩ -dependent, pertussis toxin-insensitive catecholamine secretion; indeed, even after short-term (20 minutes) exposure to PACAP and removal of the secretagogue, PC12 cells continued to secrete norepinephrine up to 76.9Ϯ0.22% of cellular norepinephrine content after 3 hours. A phospholipase C-␤ inhibitor (U-73122) blocked this extended secretory response, which was dependent on low-magnitude Ca 2ϩ influx resistant to several L-, N-, P/Q-, or T-type Ca 2ϩ channel antagonists, but sensitive to Zn 2ϩ , Ni 2ϩ , Cd 2ϩ , or to the store-operated Ca 2ϩ channel blocker SKF96365. A less than additive effect of the sarcoendoplasmic reticulum Ca 2ϩ -ATPase inhibitor thapsigargin plus PACAP on this sustained secretion also supported a contribution of store-operated Ca 2ϩ entry to the sustained secretory response. We propose that PACAP-evoked secretion and transcription are subject to homologous desensitization in PC12 cells; however, PACAP also induces long-lasting secretion, even under dose and time circumstances in which acute, dihydropyridine-sensitive secretion has been desensitized. Although initial secretion is mediated by an L-type voltage-operated Ca 2ϩ channel, extended secretion may involve a store-operated Ca 2ϩ channel that is activated through a G q/11 /phospholipase C-␤/phosphoinositide signaling pathway. (Hypertension. 1999;34:1152-1162.)
P
ituitary adenylyl cyclase-activating polypeptide (PACAP) is a member of the secretin/glucagon/vasoactive intestinal peptide (VIP) regulatory peptide family. 1, 2 This neuropeptide occurs in both 27-and 38-(PACAP38) amino acid forms. 1 PACAP exhibits a variety of biological activities including regulation of hormone production and secretion in endocrine organs such as the pituitary, thyroid, and pancreas. 3, 4 The adrenal gland is innervated by a dense network of PACAP-immunoreactive fibers, and abundant PACAP binding sites occur on the surface of chromaffin cells. 5, 6 In addition to the classic preganglionic neurotransmitter acetylcholine, the noncholinergic transmitter PACAP is likely to play an important role in governing both secretion and synthesis of catecholamines in chromaffin cells. [7] [8] [9] [10] We recently reported that PACAP triggers both catecholamine secretion and transcriptional activation of the regulated secretory protein chromogranin A in PC12 pheochromocytoma cells. 11 Other studies have suggested distinct differences between PACAP actions and those of the nicotinic cholinergic agonist acetylcholine. 9, 12 In contrast to nicotine, whose secretory response in chromaffin cells shows rapid desensitization, 13 chronic exposure of chromaffin cells to PACAP can evoke long-lasting Ca 2ϩ influx 7 and catecholamine secretion, 12 without apparent desensitization of the secretory response.
PACAP/VIP receptors belong to the large family of the 7 transmembrane-spanning guanine nucleotide-binding G protein-coupled receptors (GPCRs). Three classes of PACAP/ VIP receptors (PAC1, VPAC1, VPAC2) have been identified and cloned. 14, 15 PAC1 receptors, which have high selectivity for PACAP but low affinity for VIP, exist as 6 splice-variant forms. 15, 16 PAC1 can couple to activation of both the adenylyl cyclase (AC) and the phospholipase C-␤/phosphoinositide (PLC-␤/PI) pathways, through G s and G q/11 classes of G ␣ protein subunits. 15, 17 Sustained exposure of GPCRs to agonist generally induces desensitization of the receptor responsiveness. Rapid desensitization results from uncoupling of the heterotrimeric G protein from its receptor, as a consequence of receptor phosphorylation. 18 To date, functional desensitization of the PAC1 receptor in chromaffin cells remains uncharacterized.
In PC12 cells, PACAP-induced catecholamine secretion and chromogranin A transcription are both mediated by PAC1. 11 The present study reveals that both norepinephrine release and chromogranin A trans-activation, which are induced by PACAP, desensitize after limited preexposure of PC12 cells to very low doses of peptide (IC 50 values 18-to 32-fold less than the corresponding EC 50 values). Desensitization of secretion seems to be the consequence of diminished Ca 2ϩ influx through L-type voltage-operated Ca 2ϩ channels (VOCC). However, PACAP also triggers a potent, long-lasting, nondesensitizing catecholamine release, even under dose and time circumstances in which acute, dihydropyridine (DHP)-sensitive secretion has been desensitized. We propose that sustained catecholamine release is mediated by a G q/11 protein coupling PAC1 to the PLC-␤/PI pathway in a process that is dependent on store-operated Ca 2ϩ channels (SOCCs).
Methods

Peptides and Reagents
Synthetic PACAP38 and PACAP6-38 were from Peninsula Laboratories. Thapsigargin, bisindolylmaleimide, chelerythrine, calphostin C, flunarizine, bepridil, pertussis toxin (PTX), SKF96365, nifedipine, and caffeine were from Calbiochem Corporation. ZnCl 2 was obtained from Aldrich Chemical. Nicotine, EGTA, NiCl 2 , CdCl 2 , and ruthenium red were from Sigma Chemical Company. 2.5S NGF was from Life Technologies. U-73122, U-73343, and ryanodine were from Research Biochemicals Incorporated. -Conotoxin GVIA was from Research Biochemicals Incorporated or Alexis Corporation; -conotoxin MVIIC was obtained from Alexis Corporation.
Cell Culture
Passage 8 PC12 rat pheochromocytoma cells, which were obtained from Dr David Schubert (Salk Institute, La Jolla, Calif), were cultured in high-glucose DMEM that was supplemented with 10% heat-inactivated horse serum and 5% heat-inactivated fetal bovine serum (Gemini Bioproducts), streptomycin (100 g/mL), and penicillin (100 U/mL).
Catecholamine Secretion
Catecholamine secretion from PC12 cells was performed as previously described. 19 Briefly, cells were grown on poly-D-lysine-(Sigma Chemical Co) coated 6-well culture dishes, loaded for 2 hours with 1 Ci [ 3 H]-L-norepinephrine (71.7 Ci/mmol, DuPont-NEN), and washed with secretion medium (150 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L CaCl 2 , 10 mmol/L HEPES buffer, pH 7.4). Cells were subsequently stimulated for 20 minutes with the indicated concentrations of secretagogue in secretion medium. In some experiments, cells were preincubated for 10 minutes with indicated concentrations of PACAP before exposure for 20 minutes to stimulatory doses of PACAP. [ 3 H]-L-norepinephrine secretion was calculated as a percentage of total radioactivity (present in the cells before stimulation), in which total radioactivity is the sum of the amount released plus the amount remaining in the cells.
Ca
2؉ Uptake by PC12 Cells 45 Ca 2ϩ uptake by PC12 cells was performed as previously described 19 with minor modifications. Briefly, cells grown on poly-D-lysinecoated 6-well culture dishes were rinsed with 1 mL of release buffer (150 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L CaCl 2 , 10 mmol/L HEPES buffer, pH 7.4) every 15 minutes for 1 hour at 37°C. PC12 cells were then incubated for 2 minutes with 1 mL of Ca 2ϩ -free release buffer that contained 2 Ci of 45 Ca 2ϩ (25. 92 mCi/mg) in the presence or absence of 250 nmol/L PACAP. Ca 2ϩ uptake was concluded by the addition of 2 mL of ice-cold Ca 2ϩ -free secretion medium that contained 2 mmol/L EGTA and 1 mmol/L of LaCl 3 , with further washing 6 times with 2 mL of the same buffer. One milliliter of cell lysis buffer (secretion medium containing 0.1% Triton X-100) was added to each well and collected for scintillation counting. The data were expressed as cpm/well.
Chromogranin A Promoter/Reporter Construct and Expression Plasmids
Promoter fragment position is numbered relative to the major transcriptional (cap) site as ϩ1. pXP1200 contains 1200 bp of the mouse chromogranin A promoter (5Ј flanking region) fused to a luciferase reporter in the promoterless luciferase reporter vector pXP1. Construction of chromogranin A promoter/luciferase reporter plasmids pXP1200 was described previously. 20 
Transient Transfection Studies
Supercoiled plasmid DNA for transfection was grown in Escherichia coli strain DH-5␣ and purified on columns (Qiagen Inc). Twentyfour hours before transfection, PC12 cells were split onto poly-Dlysine-coated 6-well Falcon plates at 40% to 50% confluence. Cells were transfected with 2 g of supercoiled plasmid DNA per well, with a polycation method (Superfect, Qiagen Inc). Three hours after transfection, PC12 cells were treated for 4 hours with the indicated concentrations of PACAP. Cells were harvested as previously described 21 and assayed for luciferase reporter activity and protein concentration. Luciferase results were normalized to cell protein content.
Statistics
Values are given as the meanϮ1 SEM for triplicate determinations. Statistical analysis was performed by unpaired Student t test or by 2-way ANOVA. Differences were considered significant at PϽ0.05.
Results
PACAP-Evoked Catecholamine Secretion Is Subject to Desensitization
PACAP triggered catecholamine secretion from PC12 cells in a concentration-dependent manner. 11 Increased norepinephrine release became significant at Ն1 nmol/L peptide and reached a maximum at 1 mol/L peptide, with EC 50 Ϸ23 nmol/L ( Figure 1A ).
Previous exposure of cells to PACAP for 10 minutes, followed by washing (twice for 5 minutes), caused impairment of the subsequent stimulatory effect of 250 nmol/L PACAP on catecholamine secretion ( Figure 1B) . As illustrated in Figure 1B , desensitization of PACAP-induced secretion became significant when cells were preexposed to Ն1 nmol/L PACAP. Desensitization of subsequent secretion by prior PACAP reached a maximum at 20 to 50 nmol/L PACAP preincubation, with IC 50 Ϸ1.3 nmol/L ( Figure 1B) . Of note, desensitization of the subsequent PACAP secretory response was not observed when the wash step preceding rechallenge with PACAP was omitted (data not shown).
To exclude the possibility that the decreased secretory response observed after rechallenge with PACAP ( Figure 1B ) could reflect depletion of catecholamines in the intracellular (secretory granule) pool after preexposure to PACAP rather than true desensitization of the PACAP receptor, we examined the effect of PACAP preincubation on catecholamine secretion induced by direct membrane depolarization with 55 mmol/L KCl. Preincubation of PC12 cells with 20 nmol/L PACAP did not affect the secretory response to subsequent membrane depolarization with KCl: KCl caused 48.56Ϯ 0.27% secretion of norepinephrine, and this response was not altered by PACAP preexposure (49.01Ϯ0.57% secretion). This result indicates that prior exposure of cells to a submaximal secretory dose of PACAP has little or no effect to deplete the intracellular pool of catecholamines in secretory granules.
Because Ca 2ϩ influx through L-type VOCC mediates PACAP-induced catecholamine secretion from chromaffin cells, 7, 8, 11 we therefore investigated the effect of a desensitizing preincubation dose of PACAP (20 nmol/L) on Ca 2ϩ influx triggered by a subsequent stimulation with PACAP (250 nmol/L). As illustrated in Figure 2 , 250 nmol/L PACAP triggered 45 Ca 2ϩ uptake in PC12 cells to a value of 246Ϯ 18.5% over control (ϭ100%). Preincubation of cells with a desensitizing concentration of peptide (20 nmol/L) resulted in a substantial decrement in the subsequent PACAP-induced 45 Ca 2ϩ uptake ( Figure 2 ). Under these conditions, 45 Ca 2ϩ uptake declined to a value of 149Ϯ5.3% over control, suggesting that desensitization of the secretory response occurred at a step proximal to Ca 2ϩ influx through L-type VOCC.
PACAP Trans-Activation of Chromogranin A Transcription Is Subject to Desensitization
PACAP trans-activates a transfected chromogranin A promoter in PC12 cells in a concentration-dependent manner ( Figure 3A and Reference 11). The activity of a transfected 1200-bp chromogranin A promoter/luciferase reporter plasmid was increased significantly at 20 hours of exposure to 0.1 nmol/L PACAP, with EC 50 Ϸ10 nmol/L ( Figure 3A) . By contrast, preexposure of cells to PACAP, followed by washing, inhibited in a dose-dependent manner the subsequent stimulatory effect of 250 nmol/L PACAP on transcriptional activation of the chromogranin A promoter ( Figure 3B ). Desensitization of PACAP-induced transcription became significant when cells were preexposed to 0.1 nmol/L PACAP, and complete desensitization of transcription was reached after a 10 to 50 nmol/L PACAP preincubation (IC 50 Ϸ0.31 nmol/L, Figure 3B ). 45 Ca 2ϩ uptake. PC12 cells were preincubated for 10 minutes with secretion medium alone or 20 nmol/L PACAP38 (incubation 1). Cells were washed twice with secretion medium (2ϫ5 minutes) and were subsequently exposed to a 45 Ca 2ϩ uptake buffer supplemented or unsupplemented with 250 nmol/L PACAP38 (incubation 2). After 2 minutes of incubation, cells were washed and lysed to measure 45 Ca 2ϩ uptake.
PACAP-Evoked
hours without apparent desensitization. 12 We therefore questioned whether acute exposure of PC12 cells to PACAP could provoke such a sustained secretory response. Indeed, shortterm (Յ20 minutes) exposure of PC12 cells to 250 nmol/L PACAP elicited long-lasting catecholamine release for up to 3 hours ( Figure 4A ). Thereafter, even replacement of the PACAP-containing medium by PACAP-free medium did not impair this sustained PACAP-evoked catecholamine secretion. For example, after 1 hour of exposure to PACAPdepleted medium (ie, time segment 80 to 100 minutes), the magnitude of net norepinephrine release was similar to that measured after 20 minutes of acute exposure to PACAP. At time segment 160 to 180 minutes, norepinephrine secretion was still maintained at a value of 7.9Ϯ0.14% over basal. When cumulative catecholamine release was measured for 3 hours after an acute exposure of cells (20 minutes) to PACAP, a remarkable 76.9Ϯ0.22% of total cell content of catecholamines had been secreted (see Figure 4 legend for details of calculation). In sharp contrast, acute treatment of PC12 cells with 60 mol/L nicotine induced massive (24% net) catecholamine secretion within 20 minutes followed by a rapid decay of the response that returned to a basal secretion value within 40 to 60 minutes ( Figure 4B ).
Effect of Blockade of the Initial Phase of Catecholamine Secretion on PACAP-Induced Prolonged Secretory Response
Catecholamine release triggered by PACAP from chromaffin cells is dependent on the presence of Ca 2ϩ in the extracellular medium. 7, 8, 11 To determine whether blockade of the initial phase of the secretory response can prevent PACAP from further evoking the prolonged catecholamine release, we examined the effect of Ca 2ϩ depletion during the first 20-minute stimulation period with 250 nmol/L PACAP. Consistent with previous studies, Ca 2ϩ -deficient medium strongly impaired the secretory response triggered by PACAP within the acute, 0-to 20-minute time segment ( Figure 5A ). When Ca 2ϩ was then reintroduced together with PACAP-free secretion medium, catecholamine release resumed for cells that had been acutely exposed to PACAP and reached secretion values in the same magnitude as that observed for cells that were not deprived of Ca 2ϩ during the limited (20 minutes) exposure to PACAP ( Figure 5A ).
Effect of the PAC1 Antagonist PACAP6-38 on PACAP-Evoked Extended Catecholamine Secretion
In PC12 cells, the initial phase of catecholamine secretion that results from short-term exposure to PACAP (20 minutes) is inhibited by the PACAP fragment PACAP6-38, a potent competitive inhibitor of PAC1. 11 To assess the contribution of the PAC1 receptor to PACAP-induced long-lasting catecholamine secretion, we examined the effect of continuous exposure of cells to PACAP6-38 (5 mol/L). After a 20-minute stimulation with 250 nmol/L PACAP-38, continuous application of PACAP6-38 within the 20-to 60-minute time segment did not affect the prolonged secretory response evoked by PACAP ( Figure 5B ). However, further exposure to PACAP6-38 (Ն60 minutes) inhibited PACAP-induced extended secretion ( Figure 5B ). The delayed response to the antagonist PACAP6-38 is compatible with PACAP's previously reported high affinity (0.3 nmol/L) 22 for and slow (t 1/2 Ͼ20 minutes) dissociation 23 from the PAC1 receptor.
Lack of Involvement of L-Type VOCCs in PACAP-Induced Sustained Catecholamine Release
In PC12 cells, the initial phase of catecholamine secretion that results from short-term exposure to PACAP (20 minutes) is mediated by Ca 2ϩ influx through L-type VOCCs. 11 To determine whether PACAP-induced long-lasting secretion is also dependent on L-type Ca 2ϩ channels, we examined the effect of the DHP nifedipine, a selective L-type Ca 2ϩ -channel antagonist. Coapplication of 10 mol/L nifedipine together with 250 nmol/L PACAP-38, strongly impaired the PACAPevoked initial phase of secretion measured within the initial 0-to 20-minute time segment ( Figure 6A ). In contrast, after 
Effect of PTX or the PLC-␤ Inhibitor U73122 on PACAP-Induced Initial and Extended Catecholamine Secretion
PAC1 not only stimulates the effector AC but also transduces its signal through the PLC-␤/PI pathway in PC12 and other cell types. 4, 15, 24 Monomeric ␣ subunits of the G q family of G proteins as well as ␤␥ heterodimeric subunits of the G i/o class mediate activation of PLC-␤. 25 These 2 families of G proteins can be distinguished by their sensitivity to PTX: G proteins of the G i/o family are sensitive to ADP-ribosylation by the toxin, whereas the G q family is PTX-insensitive. To probe the type of G protein involved in both initial and long-term secretory responses stimulated by PACAP, we examined the effect of a pretreatment with PTX. Preexposure of PC12 cells to PTX (16 hours, 100 ng/mL) did not modify either initial or extended secretion evoked by 250 nmol/L PACAP (data not shown). Continuous exposure of cells to U-73122 (1 mol/ L), a selective antagonist of PLCs, after 20 minutes of stimulation with PACAP, impaired the prolonged secretory response triggered by PACAP without affecting the initial phase of the secretory response ( Figure 6B ). These findings provide evidence that both initial and long-term secretory responses triggered by PACAP in PC12 cells are mediated by a PTX-insensitive G protein, whereas only the prolonged secretory response involves a PLC-␤-mediated pathway. In contrast, the inactive isomer U-73343 (negative control) did not affect either acute or sustained PACAP-triggered catecholamine release (data not shown).
PACAP Requires Extracellular Ca 2؉ Influx for its Prolonged Effect on Catecholamine Secretion
To determine the contribution of Ca 2ϩ to PACAP-induced long-term secretion, we examined the influence of a Ca 2ϩ -deficient environment and the effect of Zn 2ϩ , a nonselective competitive inhibitor of a variety of cell surface Ca 2ϩ channels. After 20 minutes of PACAP exposure, switching to a PACAP-and Ca 2ϩ -free medium greatly impaired the longterm catecholamine secretion by PC12 cells ( Figure 7A ). Under these conditions, catecholamine release was completely abolished as early as 40 minutes after Ca 2ϩ removal. The inorganic cation Zn 2ϩ (100 mol/L) completely inhibited initial secretion (Reference 11 and Figure 7A ) and also inhibited the long-lasting secretion induced by 250 nmol/L PACAP by Ϸ65% to 85% ( Figure 7A ). Hence, these results suggest that the influx of extracellular Ca 2ϩ through cell surface channels is essential for the prolonged effect of PACAP on the secretory response. However, 45 Ca 2ϩ uptake measurement after short-term exposure to 250 nmol/L PACAP revealed a continuing, modest influx of extracellular Ca 2ϩ ( Figure 7B ). After the initial burst of Ca 2ϩ influx (t 0 Ϫt 2 minutes , Figures 2 and 7B) , long-term 45 Ca 2ϩ uptake measured during 2-minute periods of sequential 20-minute time segments was modestly, though consistently, greater than that measured -free secretion medium plus 1 mmol/L EGTA. Catecholamine secretion was evaluated as described in the legend of Figure 4 
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under basal conditions ( Figure 7B ). These results suggest that a low-magnitude influx of extracellular Ca 2ϩ , after the initial massive Ca 2ϩ influx, is at least necessary (though perhaps not sufficient) for PACAP-induced long-lasting catecholamine secretion.
Characterization of the Role of Specific Cell Surface VOCC Subtypes (N-, P-, Q-, and T-type) in Long-lasting Catecholamine Secretion Induced by PACAP
Cell membrane VOCCs have been classified physiologically or pharmacologically as L, N, P/Q, T, or R types, 26 and most of these channels (eg, L, N, and P/Q types) have been detected in PC12 cells. 27 Because the L-type VOCC inhibitor nifedipine did not impair PACAP-induced extended secretion ( Figure 6A) , we investigated the role of non-L-type Ca 2ϩ channels in this sustained secretion. We first tested the effect of a combination of 1 mol/L -conotoxin GVIA (a highly selective N-type VOCC antagonist) with 1 mol/L -conotoxin MVIIC (an N-and P/Q-type VOCC blocker). Long-lasting catecholamine release was unaltered by the combination of these 2 -conopeptides at up to 100 minutes (data not shown).
To further examine potential contributions of DHPinsensitive Ca 2ϩ channels to the prolonged secretory effect of PACAP, we used nerve growth factor (NGF; 100 ng/mL, 7 days) to differentiate the PC12 cell line. PC12 cells differentiated by NGF express both L-and N-type channels but show a preferential increase in the N-type on differentiation. 28 As in undifferentiated PC12 cells, short-term (20 minutes) exposure of NGF-treated PC12 cells to 250 nmol/L PACAP elicited long-lasting catecholamine release (data not shown). However, continuous treatment with the N-type VOCC blocker -conotoxin GVIA (5 mol/L) did not diminish the secretory response for up to 100 minutes (data not shown), suggesting that N-type Ca 2ϩ channels may not contribute to the prolonged effect of PACAP.
Finally, exposure of PC12 cells to the chemical VOCC inhibitors bepridil, a T-and L-type Ca 2ϩ channel blocker, and flunarizine, which selectively blocks T-type Ca 2ϩ channels, failed to antagonize PACAP-induced long-lasting secretion (data not shown 33 However, the contribution of cell surface SOCCs to neurotransmitter release from chromaffin cells (eg, catecholamine) remains controversial. 34, 35 SERCA inhibition by agents such as thapsigargin characteristically triggers sustained, capacitative Ca 2ϩ entry. 31, 32 As shown in Figure 8A , depletion of intracellular Ca 2ϩ stores of PC12 cells by continuous exposure to thapsigargin (1 mol/L) stimulated norepinephrine release, which showed only little desensitization for a period of up to 100 minutes. Coapplication of thapsigargin with PACAP (250 nmol/L) caused additive stimulation of secretion within the initial (0 to 20 minutes) phase. Thereafter, by 40 to 100 additional minutes in PACAP-free secretion medium, the secretory response in cells treated with initial (20 minutes) PACAP plus sustained (0 to 100 minutes) thapsigargin was no greater than in cells treated with initial PACAP alone ( Figure 8A) .
Contribution of SOCCs to Long-Lasting Catecholamine Secretion Triggered by PACAP
Taken together, our data suggest that PACAP and thapsigargin use distinct Ca 2ϩ entry pathways to elicit the initial phase (Յ20 minutes) of catecholamine release, while the less than additive effect of combined PACAP and thapsigargin during the prolonged phase of secretion suggests that the 2 compounds may share the same signaling pathway, ie, Ca 2ϩ release from intracellular stores, followed by activation of capacitative Ca 2ϩ entry. To further probe a possible contribution of SOCCs to long-lasting catecholamine secretion evoked by PACAP, we tested the effect of the imidazole derivative SKF96365, a recently characterized SOCC/non-VOCC blocker. 32, 36 After the cells were stimulated for 20 minutes with 250 nmol/L PACAP, SKF96365 (50 mol/L) markedly inhibited subsequent norepinephrine release for up to 100 minutes ( Figure 8B ), supporting the involvement of a store-operated Ca 2ϩ entry mechanism in PACAP-induced extended secretion.
Contribution of Ryanodine/Caffeine to Long-Lasting Catecholamine Secretion Triggered by PACAP
Incubation of PC12 cells with 40 mmol/L caffeine, which activates Ca 2ϩ release from ryanodine-sensitive stores, 37 did not affect the PACAP-induced extended secretory response (data not shown). Similar results were obtained when Ca 
Discussion
PACAP Signaling
PACAP is emerging as a potent peptidergic neurotransmitter that governs both secretory and biosynthetic activities of sympathoadrenal cells. [7] [8] [9] [10] We previously stated 11 that PACAP uses divergent signaling pathways in PC12 cells to evoke catecholamine secretion versus transcriptional activation of chromogranin A, a key component of secretory granules of neurons and neuroendocrine cells. PACAP signals to chromogranin A transcription through the proximal cAMP response element (CRE) in cis and through cAMP, protein kinase A (PKA), and the transcription factor CRE binding protein (CREB) in trans. By contrast, a pathway that involves cytosolic Ca 2ϩ entry through L-type voltageoperated channels is required for PACAP to stimulate catecholamine secretion. Both secretory and transcriptional responses are mediated by the PAC1 receptor in PC12 cells. 11 Indeed, the "hop" RNA-splicing variant of PAC1, as defined by Spengler et al, 15 which couples to both AC and PLC-␤, is expressed in chromaffin cells. 38 
Desensitization
Prolonged or repeated stimulation of GPCRs results in desensitization of the cell response to further or repeated stimulation. Remarkably, however, sustained exposure of chromaffin cells to PACAP can also induce long-lasting Ca 2ϩ influx 7 and catecholamine secretion, phenomena apparently at odds with desensitization. 12 We show here that PACAPinduced catecholamine secretion in PC12 cells is subject to rapid homologous desensitization, which does not result from depletion of the releasable intracellular catecholamine pool in secretory granules. Desensitization of the secretory response (IC 50 Ϸ1.3 nmol/L) occurred with Ϸ18-fold less PACAP than that required to induce secretion (EC 50 Ϸ23 nmol/L), suggesting that the signaling pathway that underlies PACAP-induced desensitization might be distinct from that mobilized during secretion. In other cell types, PACAP dissociates slowly (t 1/2 Ͼ20 minutes) from its receptor 23 ; consequently, long-lasting binding of the peptide to its receptor may underlie subsequent homologous desensitization in PC12 cells. Surprisingly, we noticed that homologous desensitization of the secretory response occurred only when preincubation of the cells with PACAP was followed by repeated washing before rechallenge with the polypeptide. After washing, partial dissociation of PACAP from its binding site might be a necessary step to achieve full desensitization/downregulation of PAC1, perhaps as a consequence of incompletely characterized changes in receptor conformation. As revealed by a Ca 2ϩ -uptake experiment, homologous desensitization results in a diminution of PACAP-triggered extracellular Ca 2ϩ influx (Figure 2 ). Previous studies by us and others 7, 8, 11 indicate that Ca 2ϩ influx through L-type channels is an essential requirement for PACAP secretory action.
PACAP-triggered trans-activation of the CRE-containing chromogranin A promoter was also subject to marked homologous desensitization (Figure 3 ). After limited preincubation of cells with PACAP, trans-activation of the chromogranin A promoter evoked by subsequent rechallenge with PACAP was inhibited (Figure 3) . Moreover, the inhibitory effect of PACAPs (10 nmol/L) 3 hour preincubation on chromogranin A promoter expression was prolonged and could still be detected after 24 hours of subsequent high-dose (250 nmol/L) PACAP (data not shown). Although we have not directly examined chromogranin A transcription, our previous findings on activation of transfected chromogranin A promoter/ luciferase reporter plasmids (Reference 11 and Figure 3 ) provide results consistent with the responses of the endogenous chromogranin A gene at the levels of both steady-state mRNA accumulation 11, 21, 39, 40 and initiation of new transcripts. 21, 39 Muller et al 41 reported that pretreatment of catecholaminergic neuron-like CATH.a cells with PACAP enhanced subsequent PACAP-induced CREB-mediated transcription, a finding in sharp contrast with our current results when considering that the chromogranin A promoter's CRE domain is sufficient to account for its PACAP stimulation. 11 The discrepancy between our findings and those of Muller et al 41 
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element in cis and through cAMP, PKA, and CREB in trans. 11 However, in CATH.a cells, both CREB protein and its mRNA are downregulated by forskolin-induced increases in cAMP. 42 
Sustained Secretion
Because the secretory response to PACAP is subject to homologous desensitization after a 10-minute preincubation (Figure 1) , the long-lasting (20 to 180 minutes) PACAP secretory response (Figure 4 ) is an initially unexpected characteristic of the PC12 cell secretory response to PACAP. The mechanism of PACAP-induced catecholamine secretion is far from being fully understood. Some studies suggest that cAMP mediates the stimulatory effect of PACAP, 9,43 whereas others report that VOCCs play a key role in secretion. 7, 8, 11 Thus, the signaling pathway that underlies the action of PACAP on catecholamine secretion remains elusive. 12 Our study reveals that PACAP exhibits dual secretory effects on PC12 cells, which can be discriminated by their sensitivity to nifedipine ( Figure 6A ): the initial phase of the secretory response may be defined as a nifedipine-sensitive response, 11 whereas the long-term response is characterized by its insensitivity to DHP. Extracellular Ca 2ϩ entry through cell surface Ca 2ϩ channels is a key event in PACAP's sustained stimulation of catecholamine release ( Figure 7A ). However, although the initial secretory event triggered by PACAP requires a massive influx of external Ca 2ϩ likely through L-type VOCCs (Figure 2 ), a lower magnitude Ca 2ϩ entry through DHP-insensitive Ca 2ϩ channels seems required to maintain long-lasting catecholamine release ( Figure 7B ).
PACAP-induced long-term secretion in undifferentiated PC12 cells was completely resistant to L-, N-, P/Q-, and T-type channel blockers. Moreover, even a transition to N-type channels in NGF-differentiated PC12 cells 28 was still unassociated with N-type channel sensitivity of prolonged secretion. Extended secretion triggered by PACAP was equivalently inhibited by the broad-spectrum Ca 2ϩ channel blockers Ni 2ϩ and Cd 2ϩ . Because acute catecholamine release initiated by PACAP in rat chromaffin cells depends on Ca 2ϩ influx through incompletely defined channels that are resistant to the actions of both DHP and -conotoxin, 9 it is tempting to speculate that the responsible Ca 2ϩ channel in rat chromaffin cells 9 corresponds to the Ca 2ϩ channel we describe to be involved in the long-lasting secretion evoked by PACAP in PC12 chromaffin cells. The finding that blockade of the initial phase of the secretory response ( Figure 5A ) did not prevent PACAP from inducing sustained release of catecholamines also supports the hypothesis of 2 distinct secretory phases. Because both the initial ( Figure 5A and Reference 11) and sustained ( Figure 7 ) secretory responses to PACAP were dependent on the presence of extracellular Ca 2ϩ and because Ca 2ϩ channel blockade inhibited each secretory response (nifedipine for initial secretion [ Figure 6 ]; inorganic divalent cations for both initial and prolonged secretion [ Figure 7 and data not shown, respectively]), exocytosis is the likely mechanism of catecholamine secretion in each case. Nonetheless, we have not explicitly confirmed exocytosis by ultrastructure or by cosecretion of costored transmitters, although Babinski et al 12 have shown cosecretion of leucineenkephalin along with catecholamines from chromaffin cells in response to PACAP.
The PAC1 receptor can couple to activation of both AC and PLC-␤, presumably through activation of G s and G q/11 proteins. 15, 24 However, the nature of the G protein involved in PACAP-stimulated catecholamine secretion remains unclear. The mechanism whereby a G-protein coupled agonist depolarizes the cell membrane can involve either direct or indirect coupling of the G-protein to an ion channel. We found that neither initial (20 minutes) nor extended (20ϽtϽ100 minutes) secretion after PACAP were mediated by PTXinsensitive G proteins, which effectively ruled out G i or G o isoforms (data not shown). However, the signaling pathways whereby PACAP evokes its short-term versus extended secretory effects seem to be quite divergent. Typically, hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLC-␤ generates IP 3 , which releases Ca 2ϩ from intracellular stores, and 1,2-diacyglycerol (DAG), which activates protein kinase C (PKC). In chromaffin cells, activation of PKC enhances catecholamine secretion. 44, 45 However, the resistance of the initial catecholamine release to the PLC-␤ inhibitor U-73122 ( Figure 6B ) leads us to exclude a contribution of the IP 3 /DAG/PKC pathway in initial secretion. Similarly, PACAP-induced initial secretion was not affected by chronic PKC inactivation 11 nor by highly selective PKC inhibitors, such as bisindolylmaleimide, chelerythrine, or calphostin C (unpublished data). Finally, the additivity of thapsigargin plus PACAP on acute stimulation of catecholamine release (Figure 9 ), together with previous observations excluding a role of caffeine/ryanodine-sensitive stores to PACAP-induced initial secretion, 11 argue against a contribution of intracellular Ca 2ϩ release to the initial secretory response after PACAP. One hypothetical mechanism for initial secretion is direct opening of L-type Ca 2ϩ channels by the G-protein G␣ s or ␤␥ subunits released by GPCR activation. 46, 47 PKA might also activate Ca 2ϩ channels 46 although we found no effect of the cAMP pathway on catecholamine secretion from PC12 cells. 11, 39 In contrast to initial secretion, inhibition of sustained catecholamine release by U-73122 suggests involvement of a G q/11 /PLC-␤/PI signaling pathway ( Figure 6B ). A recent study by Bennett et al 33 suggests that both RyR and IP 3 R activation may promote SOCC-mediated Ca 2ϩ entry in PC12 cells. However, the contribution of capacitative Ca 2ϩ entry to catecholamine release from chromaffin cells remains unsettled. 34, 35 The lack of requirement of ryanodine/caffeine-sensitive stores for sustained secretion induced by PACAP (see Results) argues against participation of these stores in long-term catecholamine release. On the other hand, the less than additive stimulatory effect of combined PACAP and SERCA inhibition on the prolonged secretion ( Figure 8A ), together with the inhibitory effect of the SOCC (non-VOCC) blocker SKF96365 ( Figure 8B ), suggests that PACAP-mediated PLC-␤ activation may trigger Ca 2ϩ release from IP 3 -sensitive intracellular stores, eventuating in the subsequent capacitative (SOCC) Ca 2ϩ influx. Direct activation of non-VOCCs by a G q/11 may also be considered as a mechanism that underlies prolonged secretion. In support of this viewpoint, the recently characterized family of Drosophila non-VOCC transient receptor potential and transient receptor potential-like channels suggest a direct activation of the transient receptor potential-like channel by G ␣11 . 48 Indeed, the transient receptor potential and transient receptor potential-like channels may represent the insect homologues of the mammalian SOCC channels. 49 
Conclusions
This work supports the hypothesis that PACAP is a potent noncholinergic neurotransmitter that governs both secretory and biosynthetic activities of sympathoadrenal cells through a signaling pathway distinct from that used by the more classical aminergic agonist acetylcholine. In conclusion, on the basis of our previous report 11 and on the current results, we present a model ( Figure 9 ) that depicts putative signal transduction pathways underlying time-dependent PACAPinduced catecholamine release and chromogranin A transcription in PC12 cells. Both the secretory and the transcriptional responses induced by PACAP are subject to desensitization. Desensitization of the secretory response is associated with decreased Ca 2ϩ influx through L-type VOCCs, suggesting a site of desensitization proximal to this channel. Concomitantly, PACAP effectively triggers prolonged catecholamine secretion that may be dependent on (1) slow dissociation of PACAP from its receptor, (2) extracellular Ca 2ϩ influx of low magnitude, and (3) mediation by a G q/11 protein. The pharmacology of the prolonged secretory response was characterized by sensitivity to broadspectrum Ca 2ϩ -channel blockade (Zn 2ϩ /Ni 2ϩ /Cd 2ϩ ), resistance to L-, N-, P/Q-, and T-type blockers, sensitivity to PLC-␤, and SOCC blockade. These findings, together with the less than additive effect of thapsigargin on PACAP-sustained secretion, strongly suggest that a store-operated Ca 2ϩ entry mechanism underlies the extended effect of PACAP on catecholamine release. Further characterization of PACAP signaling pathways will require definitive identification of the SOCC channel involved in the sustained catecholamine release; possible candidates include the mammalian homologues of the Drosophila transient receptor potential and transient receptor potential-like Ca 2ϩ entry channels. 49 
